Product Introduction:
Antiflu Oral Suspension contains Oseltamivir Phosphate, an antiviral medication utilized primarily for treating influenza, commonly known as the flu. This oral suspension formulation offers a convenient option for patients who may have difficulty swallowing capsules or tablets.
Antiflu Oral Suspension prevents the flu virus from spreading inside the body. Influenza, commonly known as flu is an infection caused by a virus. This medicine should be taken only when prescribed by a doctor. It should be used in the dose and duration as advised by your doctor. It can be taken with or without food, although taking it with food can reduce the chance of feeling or being sick (nausea or vomiting).
Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medication too early may result in a relapse of the infection or failure to protect you from the flu.
Some common side effects include nausea, vomiting, stomach pain, and diarrhea. These side effects mostly occur after the first dose of the medicine and will usually stop as treatment continues. Please consult your doctor if these side effects persist for a longer duration.
Before taking it, tell your doctor if you have problems with your heart, liver or kidneys. Avoid drinking alcohol as it may increase your risk of liver damage. Pregnant or breastfeeding mothers should consult their doctor before using this medicine.
Benefits:
- Effective in reducing the severity and duration of flu symptoms when administered within a specific timeframe after symptom onset, typically within 48 hours.
- Helps to alleviate flu-related symptoms such as fever, cough, sore throat, body aches, and fatigue.
- Can be used as a preventive measure in certain high-risk populations or during flu outbreaks to reduce the risk of infection and complications.
Side Effects:
Common side effects of Oseltamivir Phosphate oral suspension may include:
- Nausea
- Vomiting
- Headache
- Dizziness
- Diarrhea
Less common but potentially serious side effects may include:
- Allergic reactions such as rash, itching, or swelling
- Difficulty breathing
- Behavioral changes, particularly in pediatric patients
Usage Guidelines:
- Antiflu Oral Suspension should be administered orally as directed by a healthcare professional.
- The dosage and duration of treatment may vary depending on the patient’s age, weight, and severity of symptoms.
- It is essential to start treatment within 48 hours of symptom onset for optimal efficacy.
- Patients should complete the full course of treatment even if symptoms improve to prevent the development of antiviral resistance.
Drug Interactions:
- Oseltamivir Phosphate may interact with other medications, including certain antacids, antibiotics, and other antiviral drugs.
- Patients should inform their healthcare provider about all medications they are taking, including prescription, over-the-counter, herbal supplements, and vitamins.
- Specific drug interactions may vary, so it’s crucial to consult a healthcare professional for personalized advice.
Precautions:
- Antiflu Oral Suspension should not be used as a substitute for influenza vaccination.
- It may not be suitable for individuals with certain medical conditions or allergies. Consultation with a healthcare provider is essential before starting treatment.
- Pregnant or breastfeeding women should discuss the risks and benefits of using Oseltamivir Phosphate oral suspension with their healthcare provider.
In summary, Antiflu Oral Suspension containing Oseltamivir Phosphate is a valuable medication for the treatment and prevention of influenza, offering convenience and efficacy in a liquid formulation. However, like any medication, it should be used responsibly under the guidance of a healthcare professional, considering its benefits, side effects, and potential drug interactions.
SAFETY ADVICE
Alcohol
Pregnancy
Breast feeding
Driving
Kidney
Liver
Limited information is available on use of Antiflu Oral Suspension in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.